中国再生医学年报2024

INTERNATIONAL LIMITED 香港聯合交易所有限公司（「聯交所」）GEM之特點 CHARACTERISTICS OF GEM OF THE STOCKEXCHANGE OF HONG KONG LIMITED (THE“STOCK EXCHANGE”) GEM G E M h a s b e e n p o s i t i o n e d a s a m a r k e t d e s i g n e d t oaccommodate small and mid-sized companies to which ahigher investment risk may be attached than other companieslisted on the Stock Exchange. Prospective investors should beaware of the potential risks of investing in such companies andshould make the decision to invest only after due and carefulconsideration. GEMGEMGEM Given that the companies listed on GEM are generally smalland mid-sized companies, there is a risk that securities tradedon GEM may be more susceptible to high market volatility thansecurities traded on the Main Board and no assurance is giventhat there will be a liquid market in the securities traded onGEM. 香港交易及結算所有限公司及聯交所對本報告之內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就本報告全部或任何部份內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 Hong Kong Exchanges and Clearing Limited and the Stock Exchangetake no responsibility for the contents of this report, make norepresentation as to its accuracy or completeness and expresslydisclaim any liability whatsoever for any loss howsoever arising fromor in reliance upon the whole or any part of the contents of this report. 本報告旨在遵照聯交所GEM證券上市規則（「GEM上市規則」）之規定，提供有關中國再生醫學國際有 限 公 司（「本 公 司」）之 資 料。本 公 司 董 事（「董事」）對此共同及個別承擔全部責任。董事在作出一切合理查詢後確認，就彼等所知及所信，本報告所載資料在各重要方面均屬準確完備，沒有誤導或欺詐成分，且並無遺漏任何其他事項，足以令致本報告或其所載任何陳述產生誤導。 This report, for which the directors (the “Directors”) of ChinaRegenerative Medicine International Limited (the “Company”)collectively and individually accept full responsibility, includesparticulars given in compliance with the Rules Governing the Listing ofSecurities on GEM of the Stock Exchange (the “GEM Listing Rules”)for the purpose of giving information with regard to the Company.The Directors, having made all reasonable enquiries, confirm that tothe best of their knowledge and belief the information contained inthis report is accurate and complete in all material respects and notmisleading or deceptive, and there are no other matters the omissionof which would make any statement herein or this report misleading. CONTENTS目錄 Corporate Information公司資料 Chairman’s Statement主席報告 Management Discussion and Analysis管理層討論及分析 Biographical Details of Directors and Chief Executives董事及最高行政人員簡介 Corporate Governance Report企業管治報告 Environmental, Social and Governance Report 2024二零二四年環境、社會及管治報告 Directors’ Report董事會報告 Independent Auditor’s Report獨立核數師報告 Consolidated Statement of Profit or Loss綜合損益表 Consolidated Statement of Comprehensive Income綜合全面收益表 Consolidated Statement of Financial Position綜合財務狀況表 Consolidated Statement of Changes in Equity綜合權益變動表 Consolidated Statement of Cash Flows綜合現金流量表 Notes to the Consolidated Financial Statements綜合財務報表附註 Five Year Financial Summary五年財務摘要 CORPORATE INFORMATION公司資料 董事 DIRECTORS 執行董事 Executive Director 王闖先生（董事會主席及行政總裁） Mr. Wang Chuang(chairman of the Board and Chief Executive Officer) 非執行董事 Non-executive Director 曾浩賢先生（於二零二四年八月二十日辭任） Mr. Tsang Ho Yin (resigned on 20 August 2024) 獨立非執行董事 Independent Non-executive Directors 梁文輝先生劉明博士霍春玉女士 Mr. Leung Man FaiDr. Liu MingMs. Huo Chunyu 公司秘書 COMPANY SECRETARY 丘煥法先生（於二零二四年七月二日辭任）黃寶田先生（於二零二四年七月二日獲委任） Mr. Khoo Wun Fat William (resigned on 2 July 2024)Mr. Wong Po Tin (appointed on 2 July 2024) 提名委員會 NOMINATION COMMITTEE 劉明博士（提名委員會主席）梁文輝先生霍春玉女士 Dr. Liu Ming(chairman of Nomination Committee)Mr. Leung Man FaiMs. Huo Chunyu 薪酬委員會 REMUNERATION COMMITTEE 劉明博士（薪酬委員會主席）霍春玉女士梁文輝先生曾浩賢先生（於二零二四年八月二十日辭任） Dr. Liu Ming(chairman of Remuneration Committee)Ms. Huo ChunyuMr. Leung Man FaiMr. Tsang Ho Yin (resigned on 20 August 2024) 審核委員會 AUDIT COMMITTEE 梁文輝先生（審核委員會主席）劉明博士霍春玉女士 Mr. Leung Man Fai(chairman of Audit Committee)Dr. Liu MingMs. Huo Chunyu CORPORATE INFORMATION公司資料 註冊辦事處 REGISTERED OFFICE Cricket Square, Hutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman Islands Cricket Square, Hutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman Islands 總辦事處及香港主要營業地點 HEAD OFFICE AND PRINCIPAL PLACE OFBUSINESS IN HONG KONG 香港九龍尖沙咀彌敦道132號美麗華大廈2310–2318室 Suite 2310–2318, Miramar Tower132 Nathan RoadTsim Sha Tsui, KowloonHong Kong 合規主任 COMPLIANCE OFFICER 王闖先生 Mr. Wang Chuang 授權代表 AUTHORISED REPRESENTATIVES 王闖先生丘煥法先生（於二零二四年七月二日辭任）黃寶田先生（於二零二四年七月二日獲委任） Mr. Wang ChuangMr. Khoo Wun Fat William (resigned on 2 July 2024)Mr. Wong Po Tin (appointed on 2 July 2024) 主要往來銀行 PRINCIPAL BANKERS 香港上海滙豐銀行有限公司恒生銀行有限公司大新銀行有限公司華夏銀行江南農村商業銀行 Hong Kong and Shanghai Banking Corporation LimitedHang Seng Bank LimitedDah Sing Bank LimitedHuaxia BankJiangnan Rural Commercial Bank 核數師 AUDITOR 金道連城會計師事務所有限公司香港尖沙咀河內道5號普基商業中心20樓2001–02室 Linksfield CPA LimitedUnit 2001–02, 20/F., Podium Plaza5 Hanoi Road, Tsim Sha TsuiHong Kong CORPORATE INFORMATION公司資料 法律顧問 LEGAL ADVISORS 有關開曼群島法律：Conyers Dill & Pearman香港中環康樂廣場8號交易廣場第一座29樓 As to Cayman Island law:Conyers Dill & Pearman29th Floor